Drug Approval | September 28, 2022
EDQM grants CEP certificate to Supriya Lifescience for Diphenhydramine Hydrochloride
This will be an added advantage for Supriya Lifescience Limited in the European market.
This will be an added advantage for Supriya Lifescience Limited in the European market.
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
To set up 50 lifestyle modification centres across the UAE in the next 24 months
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Subscribe To Our Newsletter & Stay Updated
